Genelux doses first subject in Phase II trial of NSCLC treatment
Genelux has dosed the first subject in the Phase II VIRO-25 clinical trial in the US, designed to assess the…
All articles by Vishnu Priyan
Vishnu Priyan
-
-
Galderma reports data from Phase III trial of anti-ageing product RelabotulinumtoxinA
Swiss skincare company Galderma has reported positive data from a Phase III clinical trial of RelabotulinumtoxinA (Relfydess) for treating moderate-to-severe…
-
Find Therapeutics dosing subjects in study of FTX-101 for chronic optic neuropathy
Canadian biopharmaceutical company Find Therapeutics has dosed the first subject in a Phase I trial of its lead compound, FTX-101,…
-
Lutris ends subject enrolment in EGFRI-induced acneiform rash trial
Lutris Pharma has concluded subject enrolment in its Phase II clinical trial of LUT014, a new B-Raf inhibitor designed for…
-
Airway Therapeutics to trial drug for bronchopulmonary dysplasia in newborn babies
US-based biotechnology company Airway Therapeutics is to launch a multinational Phase III clinical trial of zelpultide alfa, a drug designed…
-
Exelixis and MSD to trial cancer therapies together in clinical collaboration
US-based biotechnology companies Exelixis and MSD have partnered to assess the potential of combining their respective cancer therapies in upcoming…
-
GSK’s depemokimab shows promise in Phase III trials for chronic rhinosinusitis
UK-based pharmaceutical company GSK has announced positive results from the Phase III ANCHOR-1 and ANCHOR-2 clinical trials of depemokimab in…
-
Repare Therapeutics doses first subject in Phase I solid tumour trial
Repare Therapeutics has dosed the first subject in its Phase I POLAR clinical trial of RP-3467, a Polθ ATPase inhibitor,…
-
CEPI to initiate Phase II trials of a Rift Valley fever vaccine in Kenya
The Coalition for Epidemic Preparedness Innovations (CEPI) is preparing to initiate Phase II clinical trials for a human vaccine candidate…
-
Mater Research initiates combined Covid-flu vaccine trial
Mater Research in Brisbane, Australia, has commenced a clinical trial for a new combined Covid-19 and flu vaccine from Novavax…